Abstract
Beta therapy is employed in post surgery to treat lesions such as pterygia, keloid and glioblastoma. The beta source most used for these purposes is 90/90Y, whose quality assurance is a challenge, because the detectors currently used for this evaluation do not satisfy the spatial resolution, the effective atomic number and the tissue equivalent conditions. The Fricke xylenol gel (FXG) has been used in several applications in radiotherapy due to its better characteristics. This dosimeter is associated with the Fe(II) to Fe(III) oxidation, post ionizing irradiation, being the final Fe(III) concentration linearly depended on the absorbed dose. The goal of this present work is to show that the FXG, with atomic effective number (Zeff) of 7.75 and high resolution (<1mm), accomplishes quality assurance for rectangular and square planar 90Sr/90Y sources. In order to demonstrate the quality assurance, calibration curves, percentage depth dose and beam profile from exposed FXG samples were analyzed and from these results, we demonstrate the potential use of the FXG dosimeter for beta source quality control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
